Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Variable Annuity
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

VALIC I - Health Sciences Fund

+ Add to Watchlist

VCHSX:US

27.10 USD 0.36 1.31%

As of 20:00:00 ET on 01/30/2015.

Snapshot for VALIC I - Health Sciences Fund (VCHSX)

Year To Date: +4.31% 3-Month: +8.88% 3-Year: +35.36% 52-Week Range: 19.39 - 27.73
1-Month: +4.31% 1-Year: +29.87% 5-Year: +28.24% Beta vs SPX: 0.97

Mutual Fund Chart for VCHSX

No chart data available.
  • VCHSX:US 27.10
  • 1M
  • 1Y
Interactive VCHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VCHSX

Valic Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine or the life sciences.

Inception Date: 09-01-2006 Telephone: 1-800-448-2542
Managers: TAYMOUR R TAMADDON
Web Site: -

Fundamentals for VCHSX

NAV (on 2015-01-30) 27.10
Assets (M) (on 2014-12-31) 744.01
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for VCHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2014-02-12) 0.13
Dividend Yield (ttm) 2.70

Fees & Expenses for VCHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.15

Top Fund Holdings for VCHSX

Filing Date: 11/30/2014
Name Position Value % of Total
Gilead Sciences Inc 353,600 35,473,152 4.858%
Alexion Pharmaceuticals Inc 178,240 34,738,976 4.758%
Allergan Inc/United States 131,600 28,147,924 3.855%
Actavis plc 85,079 23,023,228 3.153%
McKesson Corp 109,100 22,993,916 3.149%
Aetna Inc 263,300 22,970,292 3.146%
UnitedHealth Group Inc 222,100 21,905,723 3.000%
Valeant Pharmaceuticals Intern 146,833 21,356,860 2.925%
Pharmacyclics Inc 128,600 17,925,554 2.455%
Incyte Corp 229,000 17,300,950 2.369%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil